{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:15:49Z","timestamp":1784805349737,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA030483"],"award-info":[{"award-number":["R01 AA030483"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["1 F31 AA028977-01"],"award-info":[{"award-number":["1 F31 AA028977-01"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA040499"],"award-info":[{"award-number":["R01 DA040499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jchromb.2023.123725","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:38:27Z","timestamp":1682109507000},"page":"123725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS method to quantify the alcohol biomarker phosphatidylethanol 16:0\/18:1 in dried blood spots for clinical research purposes"],"prefix":"10.1016","volume":"1223","author":[{"given":"Lana M.","family":"Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lane R.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Kiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2023.123725_b0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0006-291X(87)91507-5","article-title":"Formation of phosphatidylethanol in rat brain by phospholipase D","volume":"142","author":"Gustavsson","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jchromb.2023.123725_b0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1749-6632.1991.tb33873.x","article-title":"Phosphatidylethanol formation in rat hepatocytes","volume":"625","author":"Gustavsson","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jchromb.2023.123725_b0015","doi-asserted-by":"crossref","unstructured":"G.C. Mueller, M.F. Fleming, M.A. LeMahieu, G.S. Lybrand, K.J. Barry, Synthesis of phosphatidylethanol--a potential marker for adult males at risk for alcoholism, Proceedings of the National Academy of Sciences of the United States of America. 85 (1988) 9778-9782. 10.1073\/pnas.85.24.9778.","DOI":"10.1073\/pnas.85.24.9778"},{"key":"10.1016\/j.jchromb.2023.123725_b0020","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1471-4159.1987.tb05707.x","article-title":"Phosphatidylethanol formation via transphosphatidylation by rat brain synaptosomal phospholipase D","volume":"48","author":"Kobayashi","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jchromb.2023.123725_b0025","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00216-010-3458-5","article-title":"Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS\/MS","volume":"396","author":"Gnann","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2023.123725_b0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/alcalc\/agh003","article-title":"Phosphatidylethanol formation and degradation in human and rat blood","volume":"39","author":"Aradottir","year":"2004","journal-title":"Alcohol and alcoholism (Oxford, Oxfordshire)"},{"key":"10.1016\/j.jchromb.2023.123725_b0035","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/add.15811","article-title":"Set-up of a population-based model to verify alcohol abstinence via monitoring of the direct alcohol marker phosphatidylethanol 16:0\/18:1","volume":"117","author":"Van Uytfanghe","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.jchromb.2023.123725_b0040","first-page":"1832","article-title":"Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers","volume":"22","author":"Varga","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jchromb.2023.123725_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1369-1600.2006.00040.x","article-title":"Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin","volume":"12","author":"Hartmann","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.jchromb.2023.123725_b0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/alcalc\/agv038","article-title":"Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: a prospective randomized study","volume":"50","author":"Kechagias","year":"2015","journal-title":"Alcohol and alcoholism (Oxford, Oxfordshire)."},{"key":"10.1016\/j.jchromb.2023.123725_b0055","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/acer.13062","article-title":"Characterization of the pharmacokinetics of Phosphatidylethanol 16:0\/18:1 and 16:0\/18:2 in human whole blood after alcohol consumption in a clinical laboratory study","volume":"40","author":"Javors","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jchromb.2023.123725_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2018.12.048","article-title":"An automated sample preparation approach for routine liquid chromatography tandem-mass spectrometry measurement of the alcohol biomarkers phosphatidylethanol 16:0\/18:1, 16:0\/16:0 and 18:1\/18:1","volume":"1589","author":"Casati","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2023.123725_b0065","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cca.2011.04.022","article-title":"Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood","volume":"412","author":"Zheng","year":"2011","journal-title":"Clinica. Chimica. acta; int. j. clin. chem."},{"key":"10.1016\/j.jchromb.2023.123725_b0070","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1530-0277.2012.01768.x","article-title":"Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days","volume":"36","author":"Gnann","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jchromb.2023.123725_b0075","first-page":"880","article-title":"High-Throughput LC-MS\/MS Method for Determination of the Alcohol Use Biomarker Phosphatidylethanol in Clinical Samples by Use of a Simple Automated Extraction Procedure\u2014Preanalytical and Analytical Conditions, The Journal of Applied","volume":"2","author":"Isaksson","year":"2018","journal-title":"Lab. Med."},{"key":"10.1016\/j.jchromb.2023.123725_b0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.talanta.2017.01.083","article-title":"Sensitive and precise monitoring of phosphatidylethanol in human blood as a biomarker for alcohol intake by ultrasound-assisted dispersive liquid-liquid microextraction combined with liquid chromatography tandem mass spectrometry","volume":"166","author":"Wang","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2023.123725_b0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jat\/bkz035","article-title":"Fully Automated Determination of Phosphatidylethanol 16:0\/18:1 and 16:0\/18:2 in Dried Blood Spots","volume":"43","author":"Luginbuhl","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2023.123725_b0090","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00216-011-5221-y","article-title":"LC-MS\/MS analysis of phosphatidylethanol in dried blood spots versus conventional blood specimens","volume":"401","author":"Faller","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2023.123725_b0095","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00216-015-9169-1","article-title":"Quantification of phosphatidylethanol 16:0\/18:1, 18:1\/18:1, and 16:0\/16:0 in venous blood and venous and capillary dried blood spots from patients in alcohol withdrawal and control volunteers","volume":"408","author":"Kummer","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2023.123725_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2018.01.008","article-title":"Study of measurement of the alcohol biomarker phosphatidylethanol (PEth) in dried blood spot (DBS) samples and application of a volumetric DBS device","volume":"479","author":"Beck","year":"2018","journal-title":"Clinica. Chimica. acta; int. j. clin. Chem."},{"key":"10.1016\/j.jchromb.2023.123725_b0105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1039\/c0ay00636j","article-title":"The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots","volume":"3","author":"Jones","year":"2011","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jchromb.2023.123725_b0110","first-page":"288","article-title":"Advantages and challenges of dried blood spot analysis by mass spectrometry across the total testing process","volume":"27","author":"Zakaria","year":"2016","journal-title":"Ejifcc."},{"key":"10.1016\/j.jchromb.2023.123725_b0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/aid.2012.0089","article-title":"Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure","volume":"29","author":"Castillo-Mancilla","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jchromb.2023.123725_b0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2011.05.039","article-title":"Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS\/MS detection","volume":"56","author":"Bushman","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2023.123725_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","article-title":"Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots","volume":"122","author":"Zheng","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2023.123725_b0130","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01710-17","article-title":"Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy","volume":"62","author":"Anderson","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.jchromb.2023.123725_b0135","first-page":"820","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study, The Lancet","volume":"14","author":"Grant","year":"2014","journal-title":"Infect. Dis."},{"key":"10.1016\/j.jchromb.2023.123725_b0140","unstructured":"C.B. Hare, J. Coll, R. P., J.M. Molina, K. Mayer, H. Jessen, R. Grant, J.J. De Wet, M. Thompson, E. DeJesus, R. Ebrahimi, R. Mera Giler, M. Das, D. Brainard, S. McCallister, The Phase 3 DISCOVER Study: Daily F\/TAF or F\/TDF for HIV Preexposure Prophylaxis [abstract 104], Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2019."},{"key":"10.1016\/j.jchromb.2023.123725_b0145","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1128\/AAC.01693-15","article-title":"Validation and application of a liquid chromatography-tandem mass spectrometry method to determine the concentrations of sofosbuvir anabolites in cells","volume":"59","author":"Rower","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.jchromb.2023.123725_b0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jchromb.2014.11.032","article-title":"Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS\/MS quantification, Journal of chromatography","volume":"978\u2013979","author":"Jimmerson","year":"2015","journal-title":"B, Anal. technologies in the biomed. life sciences."},{"key":"10.1016\/j.jchromb.2023.123725_b0155","unstructured":"Bioanalytical Method Validation Guidance for Industry. U.S. Department of Health and Human Services, Food and Drug Administration. 2018. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf. Accessed September 19, 2022."},{"key":"10.1016\/j.jchromb.2023.123725_b0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2023.123725_b0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/jat\/bkaa034","article-title":"Variation in the relative isomer abundance of synthetic and biologically derived phosphatidylethanols and its consequences for reliable quantification","volume":"45","author":"Luginb\u00fchl","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2023.123725_b0170","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2023.123725_b0175","article-title":"Adherence to direct-acting antiviral therapy in people actively using drugs and alcohol: the INCLUD Study","volume":"8","author":"Brooks","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.jchromb.2023.123725_b0180","unstructured":"H.H. Billett, Hemoglobin and Hematocrit, in: H.K. Walker, W.D. Hall, J.W. Hurst (Eds.) Clinical Methods: The History, Physical, and Laboratory Examinations, Butterworths Copyright \u00a9 1990, Butterworth Publishers, a division of Reed Publishing., Boston, 1990."},{"key":"10.1016\/j.jchromb.2023.123725_b0185","unstructured":"e.a. Brooks KM, Adherence and 007-TP DBS Levels in Active Drug Users with HCV: The INCLUD Trial., Conference on Retroviruses and Opportunistic Infections 2020."},{"key":"10.1016\/j.jchromb.2023.123725_b0190","doi-asserted-by":"crossref","unstructured":"M. Luginb\u00fchl, F.M. Wurst, F. St\u00f6th, W. Weinmann, C.P. Stove, K. Van Uytfanghe, Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel), Drug testing and analysis. 14 (2022) 1800-1802. 10.1002\/dta.3340.","DOI":"10.1002\/dta.3340"},{"key":"10.1016\/j.jchromb.2023.123725_b0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/alcalc\/agv120","article-title":"Stability of Phosphatidylethanol in Dry Blood Spot Cards","volume":"51","author":"Bakhireva","year":"2016","journal-title":"Alcohol and alcoholism (Oxford, Oxfordshire)."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:20:01Z","timestamp":1778620801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":39,"alternative-id":["S1570023223001356"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123725","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS method to quantify the alcohol biomarker phosphatidylethanol 16:0\/18:1 in dried blood spots for clinical research purposes","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123725"}}